ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of SH3765 Tablets in Combination With Fulvestrant in Patients With HR+/HER2- Advanced Breast Cancer.

Nanjing Sanhome Pharmaceutical, Co., Ltd. · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
hr+ / her2- advanced breast cancer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 871893
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.